EFSD/Novo Nordisk Foundation Future Leaders Award

2022

Alexander Jais: Helmholtz Centre Munich - Germany
Unbased identification of sucrose-responsive neuronal circuits in control of glucose metabolism

Niklas Mejhert: Karolinska Institute - Stockholm, Sweden
Determinants of adipocyte lipid turnover in type 2 diabetes and cardiovascular disease

Soren Fisker Schmidt: University of Southern Denmark - Odense, Denmark
Adipose tissue macrophages in diabetes: regulatory mechanisms and therapeutic potential

Zhichao Zhou: Karolinska Institute - Stockholm, Sweden
Functional role of erythrocyte-derived non-coding RNAs in diabetes-associated vascular complications

2021

Alice Adriaenssens: University of Cambridge - UK
Glucose-dependent insulinotropic polypeptide: a new player in the gut-brain axis

Rongrong Fan: Karolinska Institute - Stockholm, Schweden
From epigenetics to functional epigenetics: investigating enhancers and silencers in human metabolic tissues

Nicolas Pillon: Karolinska Institute - Stockholm, Schweden
Modulation of skeletal muscle immunometabolism to improve glucose homeostasis in type 2 diabetes

Nicolai Wewer Albrechtsen: University of Copenhagen - Denmark
Glucagon resistance in diabetes

2020

Florian Kahles: University Hospital Aachen - Germany
The role of GLP-2 in cardiovascular disease

Natalie Krahmer: Helmholtz Diabetes Center - Neuherberg, Germany
Identification of leptin regulators and sensitizers based on a proteomic map of leptin signature

Mitsugu Shimobayashi: KU Leuven - Belgium
Elucidating the mechanism of hepatic selective insulin resistance

Michaela Tencerova: Institute of Physiology - Prague, Czech Republic
Studying metabolic flexibility of bone marrow adipose tissue in obesity

2019

Claire Meek: University of Cambridge - UK
An unwelcome inheritance: childhood obesity after gestational diabetes

Trine Moholdt: Norwegian University of Science - Trondheim, Norway
Before the beginning: preconception lifestyle interventions to improve future metabolic health

Atul Shahaji Deshmukh: Copenhagen University - Denmark
Discovery of insulin sensitizing peptides and proteins for the treatment of type 2 diabetes